« Back
Assessing Diversity in Cassava through the Application of Metabolomics
Assessing Diversity in Cassava through the Application of Metabolomics
Submitted on 18 Jan 2016

Margit Drapala, Elisabete Carvalhoa, Laura Perez-Fonsa, Elliott Pricea, L. Augusto Becerra Lopez-Lavalleb, Paul D. Frasera
aSchool of Biological Sciences, Royal Holloway University of London, Egham, UK bInternational Center for Tropical Agriculture, CIAT
This poster was presented at PAG XXIV
Poster Views: 980
View poster »
Poster Abstract
Cassava (Manihot esculenta) Crantz is one of the most important root crops worldwide, providing a staple food source for over 700 million people in Africa, Asia and South America ( Despite its widespread use better varieties with improved tolerance to biotic and abiotic stresses, enhanced nutritional properties, improved post-harvest properties and high yields/productivity are required urgently to address food security needs. Unlike other crops (e.g. tomato) the tools and resources necessary for the rapid and rational development of new varieties are not available in Cassava.

Recently, the sequencing of Cassava genomes has provided the impetus for genomic/marker based breeding.

Metabolomics plays a major role in augmenting modern breeding programs. This omic technique has the ability to determine small molecules (metabolites) which represent the end-point in cellular metabolism/regulation. In the present study metabolomic platforms have been established for Cassava and used to assess the biodiversity present in Cassava germplasm collections and elucidate underlying biochemical mechanisms associated with traits of interest. Report abuse »
Creative Commons

Related Posters

Trends in histological diagnosis and mutation testing to determine suitability for targeted therapies following percutaneous lung biopsy
William Crawford, Wajid Rafai, Somil Desai, Tara Barton, Maria Tsakok

MODEL-AD: Late-Onset Alzheimer’s Disease Models
Bruce Lamb on behalf of the MODEL-AD Consortium

MODEL-AD: Characterization of Familial AD Models (5xFAD, APP/PS1, hTau, 3xTg-AD)
Adrian Oblak on behalf of the MODEL-AD Consortium

Characterizing the APOE4/Trem2R47H Mouse Model for Late Onset Alzheimer’s Disease
Harriet Williams on behalf of the MODEL-AD Consortium

Novel mouse models of late-onset Alzheimer’s disease based on GWAS
Michael Sasner on behalf of the MODEL-AD Consortium